These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1569348)
1. Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum. Porat R; Mosseri R; Kaplan E; Johns MA; Shibolet S J Infect Dis; 1992 May; 165(5):953-6. PubMed ID: 1569348 [TBL] [Abstract][Full Text] [Related]
2. Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections. Taylor PW J Med Microbiol; 1976 Nov; 9(4):405-21. PubMed ID: 794476 [TBL] [Abstract][Full Text] [Related]
3. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum. Tomás JM; Ciurana B; Benedí VJ; Juarez A J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980 [TBL] [Abstract][Full Text] [Related]
4. Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Porat R; Johns MA; McCabe WR Infect Immun; 1987 Feb; 55(2):320-8. PubMed ID: 3804440 [TBL] [Abstract][Full Text] [Related]
5. Genetical studies of serum resistance in Escherichia coli. Taylor PW J Gen Microbiol; 1975 Jul; 89(1):57-66. PubMed ID: 1097595 [TBL] [Abstract][Full Text] [Related]
6. Relatedness of O-specific lipopolysaccharide side chain genes from strains of Shigella boydii type 12 belonging to two clonal groups and from Escherichia coli O7:K1. Valvano MA; Marolda CL Infect Immun; 1991 Nov; 59(11):3917-23. PubMed ID: 1718868 [TBL] [Abstract][Full Text] [Related]
7. The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Leying H; Suerbaum S; Kroll HP; Stahl D; Opferkuch W Infect Immun; 1990 Jan; 58(1):222-7. PubMed ID: 2403532 [TBL] [Abstract][Full Text] [Related]
8. Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92. Suerbaum S; Friedrich S; Leying H; Opferkuch W Zentralbl Bakteriol; 1994 Aug; 281(2):146-57. PubMed ID: 7858342 [TBL] [Abstract][Full Text] [Related]
9. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Ciurana B; Tomás JM Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009 [TBL] [Abstract][Full Text] [Related]
10. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL; Duncan RL; Morrison DC J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676 [TBL] [Abstract][Full Text] [Related]
11. The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan. Tichaczek-Goska D; Witkowska D; Cisowska A; Jankowski S; Hendrich AB Adv Clin Exp Med; 2012; 21(3):289-99. PubMed ID: 23214191 [TBL] [Abstract][Full Text] [Related]
12. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Tomás JM; Benedí VJ; Ciurana B; Jofre J Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020 [TBL] [Abstract][Full Text] [Related]
13. Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. Correlation with an LPS variation phenomenon. Stawski G; Nielsen L; Orskov F; Orskov I APMIS; 1990 Sep; 98(9):828-38. PubMed ID: 1699558 [TBL] [Abstract][Full Text] [Related]
14. Effects of LPS, lipid A and polysaccharide from adapted strains of Escherichia coli on human leucocyte activity. Koscová H; Dubnicková M; Bukovský M; Mlynarcík D Pharmazie; 2008 Feb; 63(2):147-50. PubMed ID: 18380402 [TBL] [Abstract][Full Text] [Related]
15. Structure and genetics of a glycerol 2-phosphate-containing O-specific polysaccharide of Escherichia coli O33. Senchenkova SN; Hou W; Naumenko OI; Geng P; Shashkov AS; Perepelov AV; Yang B; Knirel YA Carbohydr Res; 2018 May; 460():47-50. PubMed ID: 29524726 [TBL] [Abstract][Full Text] [Related]
16. Determinants that increase the serum resistance of Escherichia coli. Taylor PW; Robinson MK Infect Immun; 1980 Jul; 29(1):278-80. PubMed ID: 6995340 [TBL] [Abstract][Full Text] [Related]
17. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis. Van Dijk WC; Verbrugh HA; Peters R; Van Der Tol ME; Peterson PK; Verhoef J J Med Microbiol; 1979 Feb; 12(1):123-30. PubMed ID: 372531 [TBL] [Abstract][Full Text] [Related]
18. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS). Coughlin RT; Bogard WC J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431 [TBL] [Abstract][Full Text] [Related]
19. Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum. Demonty J; De Graeve J Med Microbiol Immunol; 1982; 170(4):265-77. PubMed ID: 7048047 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. Hatano K; Goldberg JB; Pier GB J Bacteriol; 1993 Aug; 175(16):5117-28. PubMed ID: 7688717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]